Ignite Creation Date:
2024-05-06 @ 12:54 AM
Last Modification Date:
2024-10-26 @ 10:56 AM
Study NCT ID:
NCT01685138
Status:
COMPLETED
Last Update Posted:
2019-03-26
First Post:
2012-09-04
Brief Title:
LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non-Small Cell Lung Cancer |
Keywords:
| Name | View |
|---|---|
| lung adenocarcinoma | View |
| Non-Small Cell Lung Cancer | View |
| Non small cell lung carcinoma | View |
| NSCLC | View |
| ALK | View |
| LDK378 | View |
| Ceritinib | View |
| crizotinib naïve adult patients | View |
| ALK-activated non-small cell lung cancer | View |
| treatment of lung cancer after first metastasis | View |
| lung cancer | View |